Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Anca Evsei"'
Publikováno v:
Medicina, Vol 60, Iss 6, p 924 (2024)
Background and Objectives: Secretory carcinoma of the breast is an uncommon histological subtype of breast cancer. There is little research on this entity and only a few larger studies, which lack consensus. We aim to report a particular apocrine dif
Externí odkaz:
https://doaj.org/article/478514f70ec74161a4319508931d70bf
Publikováno v:
Archives of the Balkan Medical Union, Vol 56, Iss 2, Pp 150-156 (2021)
Introduction. Recent research has demonstrated that the immunohistochemical nuclear -catenin expression is a valid surrogate for CTNNB1 exon 3 mutation in endometrial carcinomas (ECs). This mutation is an independent prognostic factor which id
Externí odkaz:
https://doaj.org/article/8b96b3c6aae64a66867c8fe36e20eab4
Publikováno v:
Archives of the Balkan Medical Union, Vol 56, Iss 1, Pp 8-15 (2021)
Introduction. Immunotherapy has emerged as a potent strategy for treating advanced cancer. This generated new and exciting research, especially regarding tumour microenvironment (TME), including the immune checkpoint system, to further stratify endom
Externí odkaz:
https://doaj.org/article/72144c6c9ebe44ccaa8bff9ed630725c
Autor:
Anca EVSEI, Javier F. ANDREU, Carmen M. BLAZQUEZ MAÑA, Inmaculada M. MENDEZ COCA, Ruben CARRERA SALA, Jose A. VAZQUEZ LUQUE, Carmen M. RAMOS GUIJO, Rosa M. RODRIGUEZ MILLAN, Mircea GHEORGHE, Adelina BIRCEANU-COROBEA, Narcis COPCA
Publikováno v:
Archives of the Balkan Medical Union, Vol 55, Iss 1, Pp 146-153 (2020)
Introduction. Myofibroblastomas of the breast are rare mesenchymal lesions thought to be derived from a CD34-positive mammary stromal cell that shows a great capacity for multipotency. Cases presentation. We performed a retrospective analysis of 4
Externí odkaz:
https://doaj.org/article/a32526202de74c22879a59a1c5d537a3
Autor:
Adrian Constantin, Florin Achim, Tudor Turcu, Adelina Birceanu, Anca Evsei, Bogdan Socea, Dragos Predescu
Publikováno v:
Diagnostics, Vol 13, Iss 2, p 194 (2023)
Background: Giant gallbladder is an uncommon condition that can result from a benign pathology and rarely presents with malignancy. Intracholecystic papillary–tubular neoplasm (ICPN) is a relatively new entity first described by V. Adsay in 2012 an
Externí odkaz:
https://doaj.org/article/68c68abc7f1d4a92924bb03fca3b9aa8
Autor:
Adelina BIRCEANU COROBEA, Anca EVSEI, Cristian ROSIANU, Mircea GHEORGHE, Gabriela BIRCEANU, Maria SAJIN, Anca LUPU, Narcis COPCA
Publikováno v:
Archives of the Balkan Medical Union, Vol 53, Iss 3, Pp 316-323 (2018)
Introduction. The target pathway programmed cell death‑1 (PD‑1)/ programmed death‑ligand 1 (PD‑L1) shows clinical efficacy in solid tumors, but also in Hodgkin’s and non‑Hodgkin’s lymphoma. PD‑L1 expression most often correlates with
Externí odkaz:
https://doaj.org/article/763e22abc71e46149349b5494a35538c
Autor:
Adelina BIRCEANU COROBEA, Anca EVSEI, Cristian ROSIANU, Mircea GHEORGHE, Gabriela BIRCEANU, Narcis COPCA, Maria SAJIN, Anca LUPU
Publikováno v:
Archives of the Balkan Medical Union, Vol 53, Iss 2, Pp 232-238 (2018)
Introduction. C-MYC is one of the essential transcription factors that play a role in various cellular functions. The MYC rearrangement is associated with low overall survival and low progression-free survival, increased risk of central nervous syste
Externí odkaz:
https://doaj.org/article/e69c1a72535b44c188eb52d619d3122c
Publikováno v:
Archives of the Balkan Medical Union, Vol 52, Iss 4, Pp 453-457 (2017)
Introduction. Brunner’s gland hamartomas are very uncommon. They are small, benign lesions, frequently located in the bulb of the duodenum. Usually found incidentally during routine esophago-gastro-duodenoscopies, these lesions are frequently asymp
Externí odkaz:
https://doaj.org/article/92011208f848418c9971e2180c4db1d2
Publikováno v:
Research and Science Today. 22:117-123
Autor:
Adelina Birceanu-Corobea, Narcis Copca, Maria Sajin, Anca Evsei, Pharmacy, Bucharest, Romania, Mihai Ghita
Publikováno v:
Archives of the Balkan Medical Union, Vol 56, Iss 2, Pp 150-156 (2021)
Introduction. Recent research has demonstrated that the immunohistochemical nuclear -catenin expression is a valid surrogate for CTNNB1 exon 3 mutation in endometrial carcinomas (ECs). This mutation is an independent prognostic factor which identi